Basel Medical Group Ltd
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in BMGL.
▼ -92.6% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| SNGXSoligenix Inc | $0.38 | — | 1.2x | — | -241.65% | $8.2M |
| LUCYInnovative Eyewear Inc | $0.95 | — | 0.9x | — | -84.58% | $8.18M |
| CNSPCNS Pharmaceuticals, Inc. | $5.52 | — | 0.4x | — | -106.62% | $8.07M |
| CUPRCuprina Holdings (Cayman) LTD | $3.01 |
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.
Company description provided by Yahoo Finance.
| — |
| 2.0x |
| — |
| -1569.06% |
| $8.07M |
| ALZNAlzamend Neuro, Inc. | $1.66 | — | 9.7x | — | -373.18% | $8.01M |
| XCURExicure Inc | $1.29 | — | 3.9x | — | -168.37% | $8.44M |